File Name: core-elements.pdf
File Size: 788.27 KB
File Type: Application/pdf
Last Modified: 4 years
Status: Available
Last checked: 3 days ago!
This Document Has Been Certified by a Professional
100% customizable
Language: English
We recommend downloading this file onto your computer
The Core Elements of Hospital Antibiotic Stewardship ProgramsNational Center for Emerging and Zoonotic Infectious DiseasesDivision of Healthcare Quality Promotion CORE ELEMENTS OF HOSPITAL ANTIBIOTIC STEWARDSHIP PROGRAMS 1 CS273578-A Core Elements of Hospital Antibiotic Stewardship Programs isa publication of The National Center for Emerging and ZoonoticInfectious Diseases within the Centers for Disease Control andPrevention
Centers for Disease Control and PreventionThomas R. Frieden, MD, MPH, DirectorNational Center for Emerging and Zoonotic Infectious DiseasesBeth P. Bell, MD, MPH, DirectorSuggested citation:CDC. Core Elements of Hospital Antibiotic Stewardship Programs
Atlanta, GA: US Department of Health and Human Services, CDC;2014. Available at http://www.cdc.gov/getsmart/healthcare/implementation/core-elements.html
2 CENTERS FOR DISEASE CONTORL AND PREVENTION IntroductionAntibiotics have transformed the practice of medicine, makingonce lethal infections readily treatable and making other medicaladvances, like cancer chemotherapy and organ transplants, possible
The prompt initiation of antibiotics to treat infections has beenproven to reduce morbidity and save lives, with a recent examplebeing the rapid administration of antibiotics in the management ofsepsis.1 However, 20–50% of all antibiotics prescribed in U.S. acutecare hospitals are either unnecessary or inappropriate.2–7 Like allmedications, antibiotics have serious side effects, including adversedrug reactions and Clostridium difficile infection (CDI).8–11 Patientswho are unnecessarily exposed to antibiotics are placed at riskfor serious adverse events with no clinical benefit. The misuse ofantibiotics has also contributed to the growing problem of antibioticresistance, which has become one of the most serious and growingthreats to public health.12 Unlike other medications, the potential forspread of resistant organisms means that the misuse of antibioticscan adversely impact the health of patients who are not evenexposed to them. The Centers for Disease Control and Prevention(CDC) estimates more than two million people are infected withantibiotic-resistant organisms, resulting in approximately 23,000deaths annually.13Improving the use of antibiotics is an important patient safetyand public health issue as well as a national priority.14 The 2006CDC guideline “Management of Multi-Drug Resistant Organismsin Healthcare Settings” stated that control of multi-drug resistantorganisms in healthcare “must include attention to judiciousantimicrobial use.”15 In 2009, CDC launched the “Get Smart forHealthcare Campaign” to promote improved use of antibiotics inacute care hospitals and in 2013;16 the CDC highlighted the needto improve antibiotic use as one of four key strategies required toaddress the problem of antibiotic resistance in the U.S.13A growing body of evidence demonstrates that hospital basedprograms dedicated to improving antibiotic use, commonly referredto as “Antibiotic Stewardship Programs (ASPs),” can both optimizethe treatment of infections and reduce adverse events associatedwith antibiotic use.17, 18 These programs help clinicians improve thequality of patient care19 and improve patient safety through increasedinfection cure rates, reduced treatment failures, and increasedfrequency of correct prescribing for therapy and prophylaxis.20, 21They also significantly reduce hospital rates of CDI22–24 and antibioticresistance.25, 26 Moreover these programs often achieve these benefitswhile saving hospitals money.17, 27–30 In recognition of the urgent need CORE ELEMENTS OF HOSPITAL ANTIBIOTIC STEWARDSHIP PROGRAMS 3 to improve antibiotic use in hospitals and the benefits of antibioticstewardship programs, in 2014 CDC recommended that all acutecare hospitals implement Antibiotic Stewardship Programs.7This document summarizes core elements of successful hospitalAntibiotic Stewardship Programs. It complements existingguidelines on ASPs from organizations including the InfectiousDiseases Society of America in conjunction with the Society forHealthcare Epidemiology of America, American Society of HealthSystem Pharmacists, and The Joint Commission.6, 31, 32 There is nosingle template for a program to optimize antibiotic prescribing inhospitals. The complexity of medical decision making surroundingantibiotic use and the variability in the size and types of careamong U.S. hospitals require flexibility in implementation. However,experience demonstrates that antibiotic stewardship programs canbe implemented effectively in a wide variety of hospitals and thatsuccess is dependent on defined leadership and a coordinatedmultidisciplinary approach.33–36Summary of Core Elements of HospitalAntibiotic Stewardship Programs • Leadership Commitment: Dedicating necessary human, financial and information technology resources
• Accountability: Appointing a single leader responsible for program outcomes. Experience with successful programs show that a physician leader is effective
• Drug Expertise: Appointing a single pharmacist leader responsible for working to improve antibiotic use
• Action: Implementing at least one recommended action, such as systemic evaluation of ongoing treatment need after a set period of initial treatment (i.e. “antibiotic time out” after 48 hours)
• Tracking: Monitoring antibiotic prescribing and resistance patterns
• Reporting: Regular reporting information on antibiotic use and resistance to doctors, nurses and relevant staff
• Education: Educating clinicians about resistance and optimal prescribing
4 CENTERS FOR DISEASE CONTORL AND PREVENTION Leadership CommitmentLeadership support is critical to the success of antibiotic stewardshipprograms and can take a number of forms, including: • Formal statements that the facility supports efforts to improve and monitor antibiotic use
• Including stewardship-related duties in job descriptions and annual performance reviews
• Ensuring staff from relevant departments are given sufficient time to contribute to stewardship activities
• Supporting training and education
• Ensuring participation from the many groups that can support stewardship activities
Financial support greatly augments the capacity and impact of astewardship program and stewardship programs will often pay forthemselves, both through savings in both antibiotic expenditures andindirect costs.17, 27–30Accountability and Drug Expertise • Stewardship program leader: Identify a single leader who will be responsible for program outcomes. Physicians have been highly effective in this role.6 • Pharmacy leader: Identify a single pharmacy leader who will co-lead the program
Formal training in infectious diseases and/or antibiotic stewardshipbenefits stewardship program leaders.6, 37, 38 Larger facilitieshave achieved success by hiring full time staff to develop andmanage stewardship programs while smaller facilities report otherarrangements, including use of part-time, off-site expertise andhospitalists.33 Hospitalists can be ideal physician leaders for efforts toimprove antibiotic use given their increasing presence in inpatient care,the frequency with which they use antibiotics and their commitment toquality improvement.37, 38 The Pharmacy and Therapeutics committeeshould not be considered the stewardship team within a hospitalif only performing its traditional duties of managing the formularyand monitoring drug-related patient safety, though in some smallerfacilities the pharmacy and therapeutics committee has expanded itsrole to assess and improve antibiotic use.33–36 CORE ELEMENTS OF HOSPITAL ANTIBIOTIC STEWARDSHIP PROGRAMS 5 Key SupportThe work of stewardship program leaders is greatly enhanced by thesupport of other key groups in hospitals where they are available
• Clinicians and department heads. As the prescribers of antibiotics, it is vital that clinicians are fully engaged in and supportive of efforts to improve antibiotic use in hospitals
• Infection preventionists and hospital epidemiologists coordinate facility-wide monitoring and prevention of healthcare-associated infections and can readily bring their skills to auditing, analyzing and reporting data. They can also assist with monitoring and reporting of resistance and CDI trends, educating staff on the importance of appropriate antibiotic use, and implementing strategies to optimize the use of antibiotics.39 • Quality improvement staff can also be key partners given that optimizing antibiotic use is a medical quality and patient safety issue
• Laboratory staff can guide the proper use of tests and the flow of results. They can also guide empiric therapy by creating and interpreting a facility cumulative antibiotic resistance report, known as an antibiogram. Lab and stewardship staff can work collaboratively to ensure that lab reports present data in a way that supports optimal antibiotic use. For facilities that have laboratory services performed offsite, information provided should be useful to stewardship efforts and contracts should be written to ensure this is the case
• Information technology staff are critical to integrating stewardship protocols into existing workflow. Examples include embedding relevant information and protocols at the point of care (e.g., immediate access to facility-specific guidelines at point of prescribing); implementing clinical decision support for antibiotic use; creating prompts for action to review antibiotics in key situations and facilitating the collection and reporting of antibiotic use data.40–45 • Nurses can assure that cultures are performed before starting antibiotics. In addition, nurses review medications as part of their routine duties and can prompt discussions of antibiotic treatment, indication, and duration.46, 476 CENTERS FOR DISEASE CONTORL AND PREVENTION Implement Policies and Interventionsto Improve Antibiotic UseKey points • Implement policies that support optimal antibiotic use
• Utilize specific interventions that can be divided into three categories: broad, pharmacy driven and infection and syndrome specific
• Avoid implementing too many policies and interventions simultaneously; always prioritize interventions based on the needs of the hospital as defined by measures of overall use and other tracking and reporting metrics
Policies that support optimal antibiotic useImplement policies that apply in all situations to support optimalantibiotic prescribing, for example: • Document dose, duration, and indication. Specify the dose, duration and indication for all courses of antibiotics so they are readily identifiable. Making this information accessible helps ensure that antibiotics are modified as needed and/or discontinued in a timely manner.4, 48, 49 • Develop and implement facility specific treatment recommendations. Facility-specific treatment recommendations, based on national guidelines and local susceptibilities and formulary options can optimize antibiotic selection and duration, particularly for common indications for antibiotic use like community-acquired pneumonia, urinary tract infection, intra-abdominal infections, skin and soft tissue infections and surgical prophylaxis
Interventions to improve antibiotic useChoose interventions based on the needs of the facility as well as theavailability of resources and content expertise; stewardship programsshould be careful not to implement too many interventions at once.50Many potential interventions are highlighted in the CDC/Institute forHealthcare Improvement “Antibiotic Stewardship Driver Diagramand Change Package.”51 Assessments of the use of antibiotics asmentioned in the “Process Measures” section of this document canbe a starting point for selecting specific interventions.52Stewardship interventions are listed in three categories below: broad,pharmacy-driven; and infection and syndrome specific
CORE ELEMENTS OF HOSPITAL ANTIBIOTIC STEWARDSHIP PROGRAMS 7 Broad interventions • Antibiotic “Time outs.” Antibiotics are often started empirically in hospitalized patients while diagnostic information is being obtained. However, providers often do not revisit the selection of the antibiotic after more clinical and laboratory data (including culture results) become available.53–56 An antibiotic “time out” prompts a reassessment of the continuing need and choice of antibiotics when the clinical picture is clearer and more diagnostic information is available. All clinicians should perform a review of antibiotics 48 hours after antibiotics are initiated to answer these key questions: Does this patient have an infection that will respond to antibiotics? If so, is the patient on the right antibiotic(s), dose, and route of administration? Can a more targeted antibiotic be used to treat the infection (de-escalate)? How long should the patient receive the antibiotic(s)? • Prior authorization. Some facilities restrict the use of certain antibiotics based on the spectrum of activity, cost, or associated toxicities57 to ensure that use is reviewed with an antibiotic expert before therapy is initiated. This intervention requires the availability of expertise in antibiotic use and infectious diseases and authorization needs to be completed in a timely manner
• Prospective audit and feedback. External reviews of antibiotic therapy by an expert in antibiotic use have been highly effective in optimizing antibiotics in critically ill patients and in cases where broad spectrum or multiple antibiotics are being used.25, 58, 59 Prospective audit and feedback is different from an antibiotic ”time out” because the audits are conducted by staff other than the treating team. Audit and feedback requires the availability of expertise and some smaller facilities have shown success by engaging external experts to advise on case reviews.33Pharmacy-driven Interventions • Automatic changes from intravenous to oral antibiotic therapy in appropriate situations and for antibiotics with good absorption (e.g., fluoroquinolones, trimethoprim- sulfamethoxazole, linezolid, etc.),60, 61 which improves patient safety by reducing the need for intravenous access
8 CENTERS FOR DISEASE CONTORL AND PREVENTION • Dose adjustments in cases of organ dysfunction (e.g. renal adjustment)
• Dose optimization including dose adjustments based on therapeutic drug monitoring, optimizing therapy for highly drug-resistant bacteria, achieving central nervous system penetration, extended-infusion administration of beta- lactams, etc.62, 63 • Automatic alerts in situations where therapy might be unnecessarily duplicative including simultaneous use of multiple agents with overlapping spectra e.g. anaerobic activity, atypical activity, Gram-negative activity and resistant Gram-positive activity.64 • Time-sensitive automatic stop orders for specified antibiotic prescriptions, especially antibiotics administered for surgical prophylaxis.65 • Detection and prevention of antibiotic-related drug- drug interactions e.g. interactions between some orally administered fluoroquinolones and certain vitamins
Infection and syndrome specific interventionsThe interventions below are intended to improve prescribing forspecific syndromes; however, these should not interfere with promptand effective treatment for severe infection or sepsis
• Community-acquired pneumonia. Interventions for community-acquired pneumonia have focused on correcting recognized problems in therapy, including: improving diagnostic accuracy, tailoring of therapy to culture results and optimizing the duration of treatment to ensure compliance with guidelines.66–70 • Urinary tract infections (UTIs). Many patients who get antibiotics for UTIs actually have asymptomatic bacteriuria and not infections.71, 72 Interventions for UTIs focus on avoiding unnecessary urine cultures and treatment of patients who are asymptomatic and ensuring that patients receive appropriate therapy based on local susceptibilities and for the recommended duration.73–77 • Skin and soft tissue infections. Interventions for skin and soft tissue infections have focused on ensuring patients do not get antibiotics with overly broad spectra and ensuring the correct duration of treatment.60, 78, 79 CORE ELEMENTS OF HOSPITAL ANTIBIOTIC STEWARDSHIP PROGRAMS 9 • Empiric coverage of methicillin-resistant Staphylococcus aureus (MRSA) infections. In many cases, therapy for MRSA can be stopped if the patient does not have an MRSA infection or changed to a beta-lactam if the cause is methicillin-sensitive Staphylococcus aureus.58, 80 • Clostridium difficile infections. Treatment guidelines for CDI urge providers to stop unnecessary antibiotics in all patients diagnosed with CDI, but this often does not occur.81–84 Reviewing antibiotics in patients with new diagnoses of CDI can identify opportunities to stop unnecessary antibiotics which improve the clinical response of CDI to treatment and reduces the risk of recurrence.82, 85 • Treatment of culture proven invasive infections
Invasive infections (e.g. blood stream infections) present good opportunities for interventions to improve antibiotic use because they are easily identified from microbiology results. The culture and susceptibility testing often provides information needed to tailor antibiotics or discontinue them due to growth of contaminants.86Tracking and Reporting Antibiotic Useand OutcomesMonitoring antibiotic prescribingMeasurement is critical to identify opportunities for improvementand assess the impact of improvement efforts.87 For antibioticstewardship, measurement may involve evaluation of both process(Are policies and guidelines being followed as expected?) andoutcome (Have interventions improved antibiotic use and patientoutcomes?)
Antibiotic use process measuresPerform periodic assessments of the use of antibiotics or thetreatment of infections to determine the quality of antibiotic use
Examples include determining if prescribers have: accurately applieddiagnostic criteria for infections; prescribed recommended agentsfor a particular indication; documented the indication and plannedduration of antibiotic therapy; obtained cultures and relevant testsprior to treatment; and modified antibiotic choices appropriately tomicrobiological findings. Standardized tools such as those for druguse evaluations or antibiotic audit forms like those developed byCDC can assist in these reviews.88 Likewise, assess if antibiotics are10 CENTERS FOR DISEASE CONTORL AND PREVENTION being given in a timely manner and assess compliance with hospitalantibiotic use policies such as the documentation of dose, durationand indication or the performance of reassessments of therapy(antibiotic time outs). These reviews can be done retrospectivelyon charts which could be identified based on pharmacy records ordischarge diagnoses. If conducted over time, process reviews assessthe impact of efforts to improve use. For interventions that providefeedback to clinicians, it is also important to document interventionsand track responses to feedback (e.g., acceptance)
Antibiotic use measuresMeasure antibiotic use as either days of therapy (DOT) or defineddaily dose (DDD). DOT is an aggregate sum of days for which anyamount of a specific antimicrobial agent is administered or dispensedto a particular patient (numerator) divided by a standardizeddenominator (e.g., patient days, days present, or admissions).44, 89 Ifa patient is receiving two antibiotics for 10 days, the DOT numeratorwould be 20. An alternative measure of antibiotic use is defineddaily dose (DDD). This metric estimates antibiotic use in hospitals byaggregating the total number of grams of each antibiotic purchased,dispensed, or administered during a period of interest divided bythe World Health Organization-assigned DDD.90 DDDs are oftenavailable in facilities with pharmacy systems that cannot calculateDOTs. Compared to DOT, DDD estimates are not appropriate forchildren, are problematic for patients with reduced drug excretionsuch as renal impairment, and are less accurate for between-facility benchmarking.91 However, DDDs can be a useful measure ofprogress when tracked using a consistent methodology over time.92–95In addition to measuring overall hospital antibiotic use, antibioticstewardship programs should also focus analyses on specificantibiotic(s) and hospital locations where stewardship actions areimplemented. For example, the assessment of an intervention toimprove the treatment of community-acquired pneumonia (CAP)would be expected to impact the use of antibiotics most commonlyused to treat CAP on medical wards, rather than surgical wards
As part of the National Healthcare Safety Network (NHSN), CDC hasdeveloped an Antibiotic Use (AU) Option that automatically collectsand reports monthly DOT data, which can be analyzed in aggregateand by specific agents and patient care locations. The AU moduleis available to facilities that have information system capability tosubmit electronic medication administration records (eMAR) and/orbar coding medication records (BCMA) using an HL7 standardizedclinical document architecture. To participate in the AU option,facility personnel can work with their information technology staffand potentially with their pharmacy information software providers to CORE ELEMENTS OF HOSPITAL ANTIBIOTIC STEWARDSHIP PROGRAMS 11 configure their system to enable the generation of standard formattedfile(s) to be imported into NHSN.44, 89 As more facilities enroll in the AUoption, CDC will begin to establish risk adjusted facility benchmarksfor antibiotic use. This type of benchmarking has been helpful inimproving outcomes in hospital infection control and has beenidentified by stewardship experts as a high priority for the U.S.96Outcome measuresTrack clinical outcomes that measure the impact of interventionsto improve antibiotic use. Improving antibiotic use has a significantimpact on rates of hospital onset CDI and the current challengeof CDI in hospitals makes this an important target for stewardshipprograms.10, 18, 24, 57 An advantage of this measure is that most acutecare hospitals are already monitoring and reporting information onCDI into NHSN as part of the Centers for Medicare and MedicaidServices Hospital Inpatient Quality Reporting Program
Reducing antibiotic resistance is another important goal of efforts toimprove antibiotic use and presents another option for measurement
The development and spread of antibiotic resistance is multi-factorial and studies assessing the impact of improved antibioticuse on resistance rates have shown mixed results.97–99 The impactof stewardship interventions on resistance is best assessed whenmeasurement is focused on pathogens that are recovered frompatients after admission (when patients are under the influence of thestewardship interventions). Monitoring resistance at the patient level(i.e. what percent of patients develop resistant super-infections) hasalso been shown to be useful.99Stewardship programs can result in significant annual drug costsavings and even larger savings when other costs are included.18,20, 21, 100 These savings have been helpful in garnering support forantibiotic stewardship programs. If hospitals monitor antibioticcosts, consideration should be given to assessing the pace atwhich antibiotic costs were rising before the start of the stewardshipprogram.101 After an initial period of marked costs savings, antibioticuse patterns and savings often stabilize, so continuous decreasesin antibiotic use and cost should not be expected; however, it isimportant to continue support for stewardship to maintain gains ascosts can increase if programs are terminated.3012 CENTERS FOR DISEASE CONTORL AND PREVENTION
Single template for a program to optimize antibiotic prescribing in hospitals. The complexity of medical decision making surrounding antibiotic use and the variability in the size and types of care among U.S. hospitals require flexibility in implementation. However, experience demonstrates that antibiotic stewardship programs can
Hospital antibiotic stewardship programs can increase infection cure rates while reducing ( 7-9 ): In 2014, CDC called on all hospitals in the United States to implement antibiotic stewardship programs and released the Core Elements of Hospital Antibiotic Stewardship Programs (Core Elements) to help hospitals achieve this goal.
The following checklist is a companion to CoreElementsofHospital AntibioticStewardship Programs. Thischecklistshouldbe used to systematically assess key elements andactionstoensureoptimalantibioticprescribing andlimitoveruseand misuse ofantibiotics in hospitals. CDCrecommendsthatall hospitals implementanAntibiotic StewardshipProgram.
CDC’s Core Elements of Antibiotic Stewardship offer providers and facilities a set of key principles to guide efforts to improve antibiotic use and, therefore, advance patient safety and improve outcomes.
The Core Elements outlines structural and procedural components that are associated with successful stewardship programs. In 2015, The United States National Action Plan for Combating Antibiotic Resistant Bacteria set a goal for implementation of the Core Elements in all hospitals that receive federal funding.